Breakthrough brain cancer drug Vorasidenib for NHS
A revolutionary new brain cancer treatment that can delay tumour progression for years is poised to become available on the NHS, offering fresh hope to thousands of patients across the UK.
Category : Search result: vorasidenib
NHS rejects groundbreaking brain cancer drug vorasidenib
Thousands of British brain tumour patients denied access to revolutionary new treatment as NHS cost regulators block vorasidenib despite proven clinical benefits.
Page 1 of 1